Merrill

Covance To Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD ) today announced that it will present at the Bank of America and Merrill Lynch 2009 Health Care Conference on Thursday, May 14, 2009 at 9:20 a.m. (ET). Investors may access a live webcast of the presentation at www.cov...

Brookdale to Present at Bank of America and Merrill Lynch 2009 Health Care Conference

NASHVILLE, Tenn., May 11 /PRNewswire-FirstCall/ -- Brookdale Senior Living Inc. (NYSE: BKD ) today announced that Bill Sheriff, Chief Executive Officer, and Mark Ohlendorf, Co-President and Chief Financial Officer, will make a presentation regarding the Company at the Bank of America and Merril...

Quest Diagnostics to Speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference

MADISON, N.J., May 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Bank of America and Merrill Lynch 2009 Healthcare Conference in New York City o...

HMS Holdings Corp. to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference

NEW YORK, May 7 /PRNewswire-FirstCall/ -- HMS (Nasdaq: HMSY ) today announced that it will present at the Bank of America and Merrill Lynch 2009 Healthcare Conference, which will be held Tuesday, May 12 - Thursday, May 14 at The Palace Hotel, New York City. The Company will present on Tu...

Warner Chilcott to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

HAMILTON, BERMUDA, May 7 /PRNewswire-FirstCall/ -- Warner Chilcott Limited (Nasdaq: WCRX ) announced today that it will present at the Bank of America and Merrill Lynch Healthcare Conference on Tuesday, May 12, 2009 at 10:00 a.m. ET. Presenting for Warner Chilcott will be Roger Boissonneault, P...

Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13

LAKE FOREST, Ill., May 7 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP ), a global specialty pharmaceutical and medication delivery company, today announced that the company will present at the Bank of America and Merrill Lynch 2009 Health Care Conference on Wednesday, May 13, 2009, in New ...

Inverness Medical Innovations to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 12, 2009

WALTHAM, Mass., May 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (NYSE: IMA ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, announced today that it will attend the Bank of America ...

Mettler-Toledo International Inc. Announces Webcast of Presentation at Bank of America and Merrill Lynch Health Care Conference

COLUMBUS, Ohio, May 7 /PRNewswire-FirstCall/ -- Mettler-Toledo International Inc. (NYSE: MTD ) today announced the webcast of its presentation at the Bank of America and Merrill Lynch Health Care Conference in New York on Thursday, May 14, 2009, at 10:40 a.m. Eastern Time. To hear a live webcas...

NuVasive to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference

SAN DIEGO, May 7 /PRNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: NUVA ), a medical device company focused on developing products for minimally disruptive surgical treatments for the spine, announced today that Alex Lukianov, Chairman and Chief Executive Officer and Kevin O'Boyle, Executive Vic...

Abaxis, Inc. to Present at Bank of America and Merrill Lynch 2009 Health Care Conference

UNION CITY, Calif., May 7 /PRNewswire-FirstCall/ -- Abaxis, Inc. (Nasdaq: ABAX ), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, chief operations officer, will present at the Bank of America and Merrill Lynch 2009 Health Care Confere...

Merrill in Medical Technology

Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation

...he transaction. Intercell will fund the cash component of the transaction from existing cash reserves and expects to maintain profitability in 2008. merrill Lynch International acted as exclusive financial adviser to Intercell and Cowen and Company provided a financial fairness opinion to Iomai's Board of ...

Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials

... will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, merrill Lynch and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to rais...

DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use

... will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, merrill Lynch and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to rais...

HERmark(TM) Assay Results in Metastatic Breast Cancer Presented at the San Antonio Breast Cancer Symposium

... will be available; whether we are able to build brand loyalty and expand revenues; restrictions on the conduct of our business imposed by the Pfizer, merrill Lynch and other debt agreements; the impact of additional dilution if our convertible debt is converted to equity; and whether we will be able to rais...

Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease

...netics (ASHG) Annual Meeting on October 23-27 in San Diego, CA. This plan was announced by John Crowley, President and Chief Executive Officer, at the merrill Lynch Global Pharmaceutical, Biotech & Medtech 2007 Conference in London, United Kingdom. About Amicus Therapeutics Amicus Therapeutics is a biophar...

EntreMed Raises $20 Million to Support Clinical Development Program

...ate of lenders led by GE Healthcare Financial Services, and participated by merrill Lynch Capital, a division of merrill Lynch Business Financial Services Inc., and Oxford Finance Corporation. The...

Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences

... Presenting: Jack Lief, Arena's President and Chief Executive Officer -- merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference 2007 Presenta... Summer Time (6:20 a.m. Eastern Time, 3:20 a.m. Pacific Time) at the merrill Lynch Financial Centre in London Presenting: Jack Lief, Arena's Preside...

Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)

...isclaims any obligation to do so, whether as a result of new information, future events or otherwise. Contact: Scott Solomon Vice President Sharon merrill Associates, Inc. 617-542-5300 David Buckalew Takeda Pharmaceuticals North America, Inc. 224-554-5486 ...

Nasulin Interim Results to Be Presented at American Diabetes Association Scientific Sessions

...Pharmaceuticals, Inc. Jean DeRoche, 603-658-6136 jderoche@bentleypharm.com or Sharon merrill Associates James R. Buckley, 617-542-5300 Executive Vice President bnt@investorrelation...

Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions

...Pharmaceuticals, Inc. Jean DeRoche, 603-658-6136 jderoche@bentleypharm.com or Sharon merrill Associates Jim Buckley, 617-542-5300 bnt@investorrelations.com ...

Genetic study confirms the immune system's role in narcolepsy

... was proposed decades ago, but efforts to verify it have failed repeatedly. Current findings leave little doubt that autoimmunity plays a role," says merrill Mitler, Ph.D., a program director with the National Institute of Neurological Disorders and Stroke (NINDS). The study was funded principally by NINDS...

Carbon Disclosure Project: 'World's largest corporations seek clarity on climate change regulation'

...ed Monday Sept. 22 at the New York headquarters of merrill Lynch, one of CDP's global sponsors. The event wil...ies); Nissan Motor (Manufacturing); Barclays; merrill Lynch & Co., Inc; Munich Re; National Australia Ba...rmaceuticals); Exelon (Utilities); Citigroup; merrill Lynch & Co., Inc. (Financial Services); Cisco; E...

World's largest investor coalition seeks further disclosure on climate change and shareholder value

...be held on the CDP website, the largest database in the world on corporate climate change information. Investors that have signed up to CDP include merrill Lynch, AXA, ANZ, Banco do Brazil, Mitsubishi UFJ, AIG Investments, Barclays, RBS Group and HSBC. Legg Mason, Insurance Australia Group and the Florida...

Researchers find promising cancer-fighting power of synthetic cell-signaling molecule

...er at making cancer cells behave more normally. merrill and his collaborators have been studying sphingoli...mols should be tested against other cancer types," merrill explained. Subsequently, the researchers found ...ols affect such a wide range of tumor cell types," merrill said. "But it may be due to the involvement of sph...

Merrill in Biological Technology

Amicus Therapeutics to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference on May 13, 2009

CRANBURY, N.J., May 11 /PRNewswire-FirstCall/ -- Amicus Therapeutics (Nasdaq: FOLD ) today announced that the Company's Chief Operating Officer, Matthew R. Patterson, will be presenting at the upcoming Bank of America and Merrill Lynch Conference in New York City. Mr. Patterson's presentation...

Beckman Coulter to Present at the Bank of America and Merrill Lynch Healthcare Conference

ORANGE COUNTY, Calif., May 8 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer, and marketer of products that simplify, automate, and innovate complex biomedical testing, announced today that Scott Garrett, Beckman Coulter's chairman, president and c...

Express Scripts to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

ST. LOUIS, May 8 /PRNewswire-FirstCall/ -- Express Scripts, Inc. (Nasdaq: ESRX ) announced that it will present at the Bank of America and Merrill Lynch 2009 Healthcare Conference on May 13, 2009. The presentation will begin at 8:00 a.m. EDT at the Palace Hotel in New York City. This pres...

Sigma-Aldrich to Present at the Bank of America and Merrill Lynch 2009 Healthcare Conference on Wednesday, May 13, 2009

ST. LOUIS, May 7 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL ) will be presenting at the Bank of America and Merrill Lynch 2009 Healthcare Conference on Wednesday, May 13th at 2:00 PM Eastern Daylight Time in New York, New York. Interested parties may listen via live audio ...

Transcept Pharmaceuticals to Present at the Bank of America and Merrill Lynch 2009 Health Care Conference

RICHMOND, Calif., April 28 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. announced today that Glenn A. Oclassen, President & Chief Executive Officer, is scheduled to present at the Bank of America and Merrill Lynch 2009 Health Care Conference in New York City on Tuesday, May 12, 20...

BioMarin to Present at the Merrill Lynch Global Pharmaceutical Conference

NOVATO, Calif., Sept. 11 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN ) today announced that Joshua Grass, Vice President of Business and Corporate Development of BioMarin, will present a company update at the Merrill Lynch Global Pharmaceutical Conference in London on...

Perrigo Company to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

ALLEGAN, Mich., Feb. 5 /PRNewswire-FirstCall/ -- Perrigo Company (Nasdaq: PRGO ; TASE) announced today that Joseph Papa, Perrigo's Chairman and CEO will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on Wednesday, February 6, at 11:40 a.m. (ET)...

Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference

PRINCETON, N.J., Feb. 5 /PRNewswire-FirstCall/ -- Covance Inc. (NYSE: CVD) today announced that it will present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference on February 6th at 9:20 am ET. Investors may access a live webcast of the presentation at htt...

DiObex, Inc. to Present at Merrill Lynch Global Healthcare Conference

SAN FRANCISCO, Feb. 5 /PRNewswire/ -- DiObex, Inc., a privately held biotechnology company focused on the development of therapeutics to treat metabolic diseases, announced today that CEO David Cory will deliver a corporate presentation at the upcoming Merrill Lynch & Co, Inc. Global Pharmaceu...

Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference

ROCKVILLE, Md., Feb. 4 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI ) announced today that its presentation at the Merrill Lynch Global Pharmaceutical, Biotechnology & Medical Device Conference will be webcast and may be accessed at http://www.hgsi.com (Logo: http:...

Merrill in Biological Definition

Magnetic resonance imaging

... See also History of brain imaging Magnetic resonance force microscopy Nobel Prize controversies Reference James Mattson and merrill Simon. The Pioneers of NMR and Magnetic Resonance in Medicine: The Story of MRI . Jericho & New York: Bar-Ilan University Press, 1996. ISBN 0961...